A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors
Clinical trial NCT04495296 · RECRUITING
Trial details
- NCT number
- NCT04495296
- Sponsor
- Suzhou Transcenta Therapeutics Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-13
- Primary completion
- 2026-06-25
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.